Reagents

ELIZEN Neonatal 17-OHP Screening for Congenital Adrenal Hyperplasia

The ELIZEN Neonatal 17-OHP Screening test is an ELISA-type quantitative test for newborn screening for congenital adrenal hyperplasia. It allows for the determination of the concentration of 17-hydroxyprogesterone (17-OHP) present in a sample of blood dried on 903® or 226 blotted type paper. 

Screened Parameter

  • 17-OH-Progesterone (17-OHP)

Test Principle

The ELIZEN Neonatal 17-OHP Screening kit is a competitive ELISA: the 17-OH-progesterone and 17-OHP labeled in known quantities competitively bind to anti-17-OHP antibodies covering the microplate. The labeled 17-OHP enables the detection by colorimetry and the intensity of the measured absorbance signal is directly proportional to it. The intensity of this signal is therefore inversely proportional to the concentration of 17-OHP contained in the sample, supporting a diagnosis of congenital adrenal hyperplasia

Schéma réactionnel 17 OHP

Product Benefits

Curve and controls available on blotting paper

Protocols available in manual version or on automaton

Three different packagings to accommodate laboratory needs

Total incubation in manual version: 1h55

Total time on automate: 2h30

European production according to ISO quality criteria and CE marking

Calibration against WHO International Standard

Single-step protocol before revelation

Illness

The kit allows for congenital adrenal hyperplasia newborn screening

General Info

Product code :

  • E-GQ-192C for 192 determinations

  • E-GQ-576C for 576 determinations

  • E-GQ-1920C for 1920 determinations

Related products

They are talking about us

Go to our publications

More information ?

Contact-us
logo Zentech